stocks, data, earnings and BoE decision


BNP Paribas fall sharply

BNP Paribas, the euro zone’s biggest bank, beat estimates in the second quarter, it said Thursday.

Chesnot | Getty Images News | Getty Images

BNP Paribas shares lost 8% on Thursday morning after the French bank reported a quarterly sales miss and pushed back a profit target.

It was the largest single-day loss since March last year and shares were briefly halted, according to Reuters.

—Matt Clinch

Shell reports full-year profit beat, announces $3.5 billion share buyback

British oil giant Shell beat expectations for full-year profit and announced a $3.5 billion share buyback program.

Shell reported adjusted earnings of $28.25 billion for the full-year 2023, coming after its highest-ever annual profit of $39.9 billion the year prior.

Analysts had expected net profit of $27.5 billion, according to an LSEG-compiled consensus.

Stock Chart IconStock chart icon

hide content

Shell share price.

Read more here.

— Sam Meredith

Adidas expects higher profit, reports 2023 tailwinds from selling Yeezy stock

A London Fashion Week guest wearing red Adidas Yeezy shoes in September 2022.

Jeremy Moeller / Contributor / Getty Images

Adidas expects to nearly double its operating profit to around 500 million euros ($540 million) in 2024, the German sportswear retailer said in an unscheduled announcement after the market close Wednesday.

The company released preliminary, unaudited figures putting full-year profit at 268 million euros, sharply down from the prior year but 368 million above its previous guidance.

However, the 2024 forecast was below analyst expectations, Reuters reported, and shares were lower in pre-market trade.

Adidas said it boosted 2023 performance by 100 million euros thanks to an improved operating business, and by 268 million owing to its decision not to write off its inventory of Yeezy stock, products created by rapper Ye, formerly Kanye West.

Adidas terminated its partnership with the musician in October 2022, with pressure mounting on the company after he made several antisemitic comments online. Yeezy had been a commercial success for Adidas, generating nearly $2 billion a year, according to analysts.

After initially considering scrapping its leftover Yeezy stock, with an estimated retail value of $1 billion, Adidas decided in mid-2023 to sell it. The first tranche generated 400 million euros.

On Thursday, the company said it would sell remaining stock “for at least the cost price.”

The preliminary results also show Adidas currency-neutral revenues were flat year on year in 2023, and reported sales were down 5% to 21.4 billion euros.

Stock Chart IconStock chart icon

hide content

Adidas share price.

Deutsche Bank profit smashes estimates

Illustration shows the logo of Deutsche Bank Brussels, Saturday 25 March 2023.

Nicolas Maeterlinck | Afp | Getty Images

Deutsche Bank reported fourth-quarter net profit of 1.3 billion euros ($1.4 billion), well ahead of expectations.

It marked an almost 30% fall from the same quarter a year ago, but was significantly higher than the 785.61 million euros expected by analysts.

The bank also announced plans to hike share buybacks and dividends by 50%, returning 1.6 billion euros to shareholders.

Stock Chart IconStock chart icon

hide content

Deutsche Bank share price.

Read more here.

— Elliot Smith

CNBC Pro: Jefferies names its ‘highest-conviction’ stocks to buy — and one has 118% upside

Investment bank Jefferies has revealed its top stock picks that are exposed to major themes like innovation, new products, and emerging markets.

A Chinese e-commerce giant, a chip stock, a European bank, an insurance giant, and a medical device maker are among the investment bank’s “top picks,” with one stock expected to rise by 118% over the next 12 months.

CNBC Pro subscribers can read more here.

— Ganesh Rao

CNBC Pro: Want to cash in on the weight-loss drug boom? Morgan Stanley names 4 global stocks

Drug manufacturers such as Eli Lilly and Novo Nordisk have been hot favorites among investors in the past year, given positive reception to their weight-loss medications.

“The uptake of GLP-1 (glucagon-like-pepitide-1) class AOMs (anti-obesity medications) has been unexpectedly robust, particularly in the U.S. where the drugs are propelling weight-centric goals to therapeutic guidelines,” Morgan Stanley’s analysts noted.

The implication of the drugs has been “less clear” for Asia, however, the investment bank said as it named several opportunities – and top stocks – to play the theme in the region.

CNBC Pro subscribers can read more here.

— Amala Balakrishner

European markets: Here are the opening calls

European markets are set to open lower Thursday.

The U.K.’s FTSE 100 index is expected to open 23 points higher at 7,619, Germany’s DAX down 42 points at 16,850, France’s CAC down 12 points at 7,642 and Italy’s FTSE MIB 16 points lower at 30,856, according to data from IG. 

Earnings are set to come from Shell, Deutsche Bank, ABB, Roche, Julius Baer, Sanofi and BNP Paribas.

Preliminary inflation data for the euro zone in January is also due Thursday, with markets keen to get the latest gauge on the direction of travel for consumer prices.

— Holly Ellyatt



Read More:stocks, data, earnings and BoE decision

2024-02-01 08:17:00

Get real time updates directly on you device, subscribe now.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More